Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 07, 2021

SELL
$2.75 - $6.57 $137,500 - $328,500
-50,000 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$1.38 - $3.01 $69,000 - $150,500
50,000 New
50,000 $131,000
Q4 2020

Feb 10, 2021

SELL
$1.38 - $3.01 $69,000 - $150,500
-50,000 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$1.58 - $4.77 $79,000 - $238,499
50,000 New
50,000 $87,000
Q3 2020

Nov 10, 2020

SELL
$1.58 - $4.77 $79,000 - $238,499
-50,000 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$3.74 - $6.28 $187,000 - $314,000
50,000 New
50,000 $220,000
Q2 2020

Aug 07, 2020

SELL
$3.74 - $6.28 $187,000 - $314,000
-50,000 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$2.33 - $12.98 $116,500 - $649,000
50,000 New
50,000 $196,000
Q1 2020

May 08, 2020

SELL
$2.33 - $12.98 $116,500 - $649,000
-50,000 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$6.75 - $11.15 $337,500 - $557,500
50,000 New
50,000 $535,000
Q4 2019

Feb 12, 2020

SELL
$6.75 - $11.15 $337,500 - $557,500
-50,000 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$8.57 - $10.72 $428,500 - $536,000
50,000 New
50,000 $430,000
Q3 2019

Nov 08, 2019

SELL
$8.57 - $10.72 $428,500 - $536,000
-50,000 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$7.58 - $10.0 $379,000 - $500,000
50,000 New
50,000 $411,000
Q2 2019

Aug 09, 2019

SELL
$7.58 - $10.0 $379,000 - $500,000
-50,000 Closed
0 $0
Q4 2018

Mar 04, 2019

BUY
$5.75 - $21.85 $287,500 - $1.09 Million
50,000 New
50,000 $321,000
Q4 2018

Feb 08, 2019

SELL
$5.75 - $21.85 $287,500 - $1.09 Million
-50,000 Closed
0 $0
Q3 2018

Nov 12, 2019

BUY
$16.81 - $24.58 $840,499 - $1.23 Million
50,000 New
50,000 $1.12 Million
Q3 2018

Nov 09, 2018

SELL
$16.81 - $24.58 $840,499 - $1.23 Million
-50,000 Closed
0 $0
Q2 2018

Aug 12, 2019

BUY
$18.6 - $24.94 $930,000 - $1.25 Million
50,000 New
50,000 $964,000
Q2 2018

Jul 23, 2018

SELL
$18.6 - $24.94 $930,000 - $1.25 Million
-50,000 Closed
0 $0
Q1 2018

May 15, 2019

BUY
$20.86 - $26.6 $1.04 Million - $1.33 Million
50,000 New
50,000 $1.15 Million
Q1 2018

May 09, 2018

SELL
$20.86 - $26.6 $1.04 Million - $1.33 Million
-50,000 Closed
0 $0
Q4 2017

Mar 05, 2018

BUY
$20.9 - $49.36 $1.04 Million - $2.47 Million
50,000 New
50,000 $1.23 Million
Q4 2017

Feb 09, 2018

SELL
$20.9 - $49.36 $1.04 Million - $2.47 Million
-50,000 Closed
0 $0
Q3 2017

Nov 13, 2018

BUY
$39.62 - $46.17 $1.98 Million - $2.31 Million
50,000 New
50,000 $2.12 Million
Q3 2017

Nov 07, 2017

SELL
$39.62 - $46.17 $1.98 Million - $2.31 Million
-50,000 Closed
0 $0
Q3 2016

Nov 13, 2017

BUY
N/A
50,000
50,000 $0

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $131M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.